|
Supplemental for Detection of Glycopeptides of MCI in Patient Serum |
3R01CA160254-11S1 |
|
NCI |
2022 |
|
sEcad as a novel target and therapy for IGF-1R expressing tumors |
3R01CA194409-08S1 |
|
NCI |
2022 |
|
Hedgehog/GLI1-mediated regulation of DNA repair in cancer, aging and neurodegenerative diseases |
3R01CA219187-05S1 |
|
NCI |
2022 |
|
Human Endogenous retroviruses as potential early markers for Alzheimers disease |
3R01CA226570-04S1 |
|
NCI |
2022 |
|
The Role of 27-hydroxycholesterol in Breast Cancer: A Population-Based Multiethnic Study |
3R01CA229815-04S1 |
|
NCI |
2022 |
|
Evaluating ADGRB3 as a tumor suppressor epigenetically silenced in WNT medulloblastoma |
3R01CA235162-04S1 |
|
NCI |
2022 |
|
Design of de novo interleukin mimics for targeted immunotherapy |
3R01CA240339-04S1 |
|
NCI |
2022 |
|
Transcriptome-wide association studies for Alzheimer’s disease integrating RNA splicing and gene expression from multiple tissues |
3R01CA242929-04S1 |
|
NCI |
2022 |
|
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects |
3R01CA248103-02S1 |
|
NCI |
2022 |
|
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects |
3R01CA248103-02S2 |
|
NCI |
2022 |